Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,157 | 12,689 | 6,062 | 7,180 | 5,210 |
| TOTAL | $9,940 | $12,965 | $6,462 | $7,986 | $5,590 |
| Non-Current Assets | |||||
| PPE Net | 54 | 56 | 58 | 62 | 62 |
| Intangibles | 254 | 254 | 254 | 137 | 137 |
| Other Non-Current Assets | 676 | 689 | 701 | 2,262 | 2,274 |
| TOTAL | $984 | $999 | $1,013 | $2,461 | $2,473 |
| Total Assets | $10,923 | $13,964 | $7,475 | $10,446 | $8,063 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 618 | 415 | 286 | 185 | 477 |
| Accrued Expenses | 1,009 | 1,695 | 2,377 | 1,725 | 1,690 |
| Other current liabilities | 12 | 10 | 10 | N/A | N/A |
| TOTAL | $1,867 | $2,171 | $2,722 | $1,958 | $2,213 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,072 | 1,062 | 1,221 | 1,288 | 1,021 |
| TOTAL | $1,095 | $1,085 | $1,245 | $1,288 | $1,021 |
| Total Liabilities | $2,962 | $3,256 | $3,967 | $3,246 | $3,234 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 38 | 38 | 33 | 32 |
| Common Shares | 26 | 24 | 21 | 20 | 18 |
| Retained earnings | -57,699 | -53,851 | -50,943 | -45,112 | -40,795 |
| TOTAL | $7,961 | $10,707 | $3,508 | $7,200 | $4,829 |
| Total Liabilities And Equity | $10,923 | $13,964 | $7,475 | $10,446 | $8,063 |